Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge

J Virol. 1993 Dec;67(12):7673-6. doi: 10.1128/JVI.67.12.7673-7676.1993.

Abstract

The IE62 protein, the primary regulatory protein of varicella-zoster virus (VZV) and the major component of the virion tegument, was an effective immunogen in the guinea pig model of VZV infection, whereas the ORF 29 gene product, a nonstructural DNA replication protein, did not elicit protection. All animals immunized with the ORF 29 protein had cell-associated viremia compared with 2 of 11 guinea pigs given the IE62 protein (P = 0.005). VZV was detected in ganglia from 38% of the animals given the ORF 29 protein and 44% of the control animals compared with 9% of the animals immunized with the IE62 protein (P = 0.04). In contrast to the IE62 protein, immunization with the ORF 29 protein did not prime the animals for an enhanced T-cell response upon challenge with infectious virus. The VZV IE62 protein has potential value as a vaccine component.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Chickenpox / prevention & control*
  • DNA-Binding Proteins / immunology
  • DNA-Binding Proteins / therapeutic use
  • Ganglia / microbiology
  • Guinea Pigs
  • Immediate-Early Proteins / immunology
  • Immediate-Early Proteins / therapeutic use*
  • Immunization*
  • Leukocytes, Mononuclear / microbiology
  • T-Lymphocytes / immunology
  • Trans-Activators / immunology
  • Trans-Activators / therapeutic use*
  • Trigeminal Ganglion / microbiology
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology
  • Viral Envelope Proteins / therapeutic use*
  • Viral Vaccines / immunology
  • Viral Vaccines / therapeutic use*
  • Viremia / prevention & control
  • Weaning

Substances

  • DNA-Binding Proteins
  • IE62 protein, Human herpesvirus 3
  • Immediate-Early Proteins
  • Trans-Activators
  • Viral Envelope Proteins
  • Viral Vaccines
  • glycoprotein gp2, varicella-zoster virus